GDP – Good Distribution Practice

The working group consists of representatives from various industries, including wholesalers, manufacturers, transporters/logistics providers, service providers, and consultants. Thus, all areas of the pharmaceutical supply chain affected by Good Distribution Practice (GDP) are represented.

The focus of the group’s work is the joint exchange of information on GDP-relevant issues. This includes discussions on best practices, the exchange of experiences with authorities, and the monitoring and interpretation of regulatory requirements.